“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...

Dividend stocks have historically outperformed non-dividend payers. Dividend stocks can make great long-term investments.

Which is the best dividend aristocrat to buy in 2020? A dividend stock battle of consumer goods and healthcare giants!

Learn about three different great dividend stock options. We cover why they are excellent choices and what strategy to use ...

Historically, Johnson & Johnson has been a fairly stable stock to own. Johnson & Johnson (NYSE: JNJ) has been a leading ...

Key Points The investment advisor sold 38,037 shares for a total of $6.31 million in Q2 2025.Move removes JNJ from portfolio, freeing capital for other top holdings.As much as 5.1% of Andrew Hill's ...

I am a passive income investor. I make my money work for me and get more money to invest. This way, I can supplement my ...

Medtronic is approaching five decades of dividend growth. AbbVie rose to the challenge when its Humira patent expired, ...

Time is one of investors' greatest allies. With enough patience, even a relatively small sum of money invested in an ...

JNJ which has outperformed the S&P 500 and other large-cap healthcare peers in H1-2025, now faces a crucial test with Q2 ...

The stock has a high yield at 3.9%, which is significantly higher than well-known Dividend Kings like Coca-Cola or Procter & ...